Perspective Therapeutics (CATX) Notes Payables (2023 - 2026)

Perspective Therapeutics has disclosed Notes Payables across 4 years of filings, most recently posting $57000.0 for Q2 2026.

• In Q2 2026, Notes Payables rose 5.56% year-over-year to $57000.0; the TTM figure through Jun 2026 stood at $57000.0 (up 5.56% YoY), while the FY2025 annual figure was $56000.0, up 7.69% from the prior year.
• Notes Payables came in at $57000.0 for Q2 2026 at Perspective Therapeutics, up from $56000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $80000.0 in Q1 2023 to a low of $48000.0 in Q3 2023.
• Average Notes Payables over 4 years is $56142.9, with a median of $54000.0 recorded in 2024.
• Year-over-year, Notes Payables sank 37.5% in 2024 and grew 7.84% in 2025.
• Over 4 years, Notes Payables stood at $49000.0 in 2023, then grew by 6.12% to $52000.0 in 2024, then grew by 7.69% to $56000.0 in 2025, then advanced by 1.79% to $57000.0 in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $57000.0 in Q2 2026, $56000.0 in Q1 2026, and $56000.0 in Q4 2025.